190 related articles for article (PubMed ID: 20843905)
1. Characteristics of patients with juvenile onset systemic sclerosis in an adult single-center cohort.
Foeldvari I; Nihtyanova SI; Wierk A; Denton CP
J Rheumatol; 2010 Nov; 37(11):2422-6. PubMed ID: 20843905
[TBL] [Abstract][Full Text] [Related]
2. Juvenile systemic sclerosis: report of three cases and review of Japanese published work.
Aoyama K; Nagai Y; Endo Y; Ishikawa O
J Dermatol; 2007 Sep; 34(9):658-61. PubMed ID: 17727371
[TBL] [Abstract][Full Text] [Related]
3. A case of juvenile systemic sclerosis with disease onset at six months old.
Sato S; Ishida W; Takehara K
Clin Rheumatol; 2003 May; 22(2):162-3. PubMed ID: 12740689
[TBL] [Abstract][Full Text] [Related]
4. Juvenile systemic sclerosis: a follow-up study of eight patients.
Szamosi S; Maródi L; Czirják L; Ellenes Z; Szücs G
Ann N Y Acad Sci; 2005 Jun; 1051():229-34. PubMed ID: 16126963
[TBL] [Abstract][Full Text] [Related]
5. Autoantibody profiles in systemic sclerosis: predictive value for clinical evaluation and prognosis.
Hamaguchi Y
J Dermatol; 2010 Jan; 37(1):42-53. PubMed ID: 20175839
[TBL] [Abstract][Full Text] [Related]
6. Systemic sclerosis in childhood: clinical and immunologic features of 153 patients in an international database.
Martini G; Foeldvari I; Russo R; Cuttica R; Eberhard A; Ravelli A; Lehman TJ; de Oliveira SK; Susic G; Lyskina G; Nemcova D; Sundel R; Falcini F; Girschick H; Lotito AP; Buoncompagni A; Sztajnbok F; Al-Mayouf SM; Orbàn I; Ferri C; Athreya BH; Woo P; Zulian F;
Arthritis Rheum; 2006 Dec; 54(12):3971-8. PubMed ID: 17133611
[TBL] [Abstract][Full Text] [Related]
7. Juvenile and young adult-onset systemic sclerosis share the same organ involvement in adulthood: data from the EUSTAR database.
Foeldvari I; Tyndall A; Zulian F; Müller-Ladner U; Czirjak L; Denton C; Kowal-Bielecka O; Bancel DF; Matucci-Cerinic M
Rheumatology (Oxford); 2012 Oct; 51(10):1832-7. PubMed ID: 22728264
[TBL] [Abstract][Full Text] [Related]
8. Clinical and laboratory features dependent on age at onset in Japanese systemic sclerosis.
Hasegawa M; Hatta Y; Matsushita T; Hamaguchi Y; Fujimoto M; Takehara K
Mod Rheumatol; 2013 Sep; 23(5):913-9. PubMed ID: 22990335
[TBL] [Abstract][Full Text] [Related]
9. A case of systemic sclerosis with anticentromere, antitopoisomerase I, and anti-U1RNP antibodies.
Sato S; Ihn H; Soma Y; Shimozuma M; Shishiba T; Takehara K
J Rheumatol; 1993 Nov; 20(11):1961-3. PubMed ID: 8308786
[TBL] [Abstract][Full Text] [Related]
10. Influence of clinical features, serum antinuclear antibodies, and lung function on survival of patients with systemic sclerosis.
Jacobsen S; Ullman S; Shen GQ; Wiik A; Halberg P
J Rheumatol; 2001 Nov; 28(11):2454-9. PubMed ID: 11708418
[TBL] [Abstract][Full Text] [Related]
11. Late onset systemic sclerosis with seronegativity: a rare presentation of an uncommon disease.
Saxena D; Jain D; Yadav M; Giri K; Yadav T; Jain P
Reumatismo; 2019 Oct; 71(3):166-170. PubMed ID: 31649382
[TBL] [Abstract][Full Text] [Related]
12. Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset disease.
Scalapino K; Arkachaisri T; Lucas M; Fertig N; Helfrich DJ; Londino AV; Steen VD; Medsger TA
J Rheumatol; 2006 May; 33(5):1004-13. PubMed ID: 16583463
[TBL] [Abstract][Full Text] [Related]
13. Elevation of IgG levels is a serological indicator for pulmonary fibrosis in systemic sclerosis with anti-topoisomerase I antibodies and those with anticentromere antibody.
Komura K; Yanaba K; Ogawa F; Shimizu K; Takehara K; Sato S
Clin Exp Dermatol; 2008 May; 33(3):329-32. PubMed ID: 18312458
[TBL] [Abstract][Full Text] [Related]
14. Anti-topoisomerase I autoantibodies in systemic sclerosis.
Czömpöly T; Simon D; Czirják L; Németh P
Autoimmun Rev; 2009 Jul; 8(8):692-6. PubMed ID: 19393194
[TBL] [Abstract][Full Text] [Related]
15. Immunoblotting on HEp-2 cells increases the detection of antitopoisomerase 1 antibodies in patients with systemic sclerosis.
Tamby MC; Servettaz A; Guilpain P; Tamas N; Berezné A; Batteux F; Reinbolt J; Guillevin L; Weill B; Mouthon L
Clin Immunol; 2007 Apr; 123(1):82-8. PubMed ID: 17258939
[TBL] [Abstract][Full Text] [Related]
16. [Comparison of three methods for the detection of anti-SCL70 autoantibodies].
Yalaoui S; Gorgi Y; Ayed K
Ann Biol Clin (Paris); 2001; 59(5):639-42. PubMed ID: 11602398
[No Abstract] [Full Text] [Related]
17. Systemic sclerosis in childhood.
Foeldvari I
Rheumatology (Oxford); 2006 Oct; 45 Suppl 3():iii28-9. PubMed ID: 16987828
[TBL] [Abstract][Full Text] [Related]
18. [Scleroderma associated autoantibodies - clinical and diagnostic relevance].
Mierau R; Genth E
Z Rheumatol; 2006 Jul; 65(4):279-84. PubMed ID: 16788839
[TBL] [Abstract][Full Text] [Related]
19. Determinants of morbidity and mortality of systemic sclerosis in Canada.
Al-Dhaher FF; Pope JE; Ouimet JM
Semin Arthritis Rheum; 2010 Feb; 39(4):269-77. PubMed ID: 18706680
[TBL] [Abstract][Full Text] [Related]
20. Direct binding of anti-DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis.
Hénault J; Tremblay M; Clément I; Raymond Y; Senécal JL
Arthritis Rheum; 2004 Oct; 50(10):3265-74. PubMed ID: 15476238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]